Protara Therapeutics, Inc. Preferred Stock Convertible Shares Issuable
Protara Therapeutics, Inc. (TARA) had Preferred Stock Convertible Shares Issuable of 8.03 thousand shares as of 2021-12-31, per its 10-Q filed 2022-05-05.
Discontinued › Notes › Stockholders' Equity Note › Class of Stock Disclosures
us-gaap:PreferredStockConvertibleSharesIssuable · last filed 2022-05-05
- 2021-12-31: Preferred Stock Convertible Shares Issuable 8.03K shares.
| Period end | Preferred Stock Convertible Shares Issuable |
|---|---|
| 2021-12-31 | 8.03K shares 10-Q · filed 2022-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |